Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.
By Bryce D. Smith, R. Morgan, G. Beckett, Y. Falck-Ytter, D. Holtzman, C. Teo, Amy Jewett, Brittney N. Baack, David B. Rein, N. Patel and 3 more. MMWR Recommendations and Reports, 2012
1,063 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/0771b1238839ae3ea77590434a1e5fc931833e01
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Annual Report to the Nation on the Status of Cancer, 1975–2012, Featuring the Increasing Incidence of Liver Cancer (2016, unknown): “Thus, in 2012, the CDC recommended 1time HCV testing for individuals born during 1945 through 1965 (ages 47-67 years in 2012).(31) The following year, the USPSTF issued similar recommendations.”
- Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (2019, unknown): “(13) Based on these data, both the CDC and the US Preventive Services Task Force (USPSTF) recommended one-time hepatitis C screening of all individuals in this birth cohort (19451965) regardless of risk factors.(14,15) Since these recommendations were established in 2012, HCV epidemiology in the Uni”
- Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 (2014, unknown): “For this reason, the Centers for Disease Control and Prevention recently augmented existing risk-based policies for HCV testing to recommend a 1-time HCV test for all persons born during this period (18).”
- Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus (2015, methodology): “The cost-effectiveness of one-time birth cohort testing is comparable to that of current risk-based screening strategies.(5)”
- Age and Cancer Risk (2014, unknown): “New antiviral treatments are available that can halt HCV-related disease progression and provide a cure for HCV infection in most people.(64,65) The CDC recommends one-time testing for HCV among adults born during 1945–1965 as a strategy for reducing HCVrelated morbidity and mortality.”